arrow
F

Filip De Vos

Utrecht University
H指数:45
被引数:9,581

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

HYPOFRACTIONATED CHEMORADIATION FOR NEWLY DIAGNOSED GLIOBLASTOMA: A MULTICENTER RANDOMIZED CLINICAL TRIAL IN THE NETHERLANDS

低分割化疗放疗用于新诊断胶质母细胞瘤:荷兰一项多中心随机临床试验

2025-11-010
OAAI
Patient Reported Outcome Measures and Quality of Life from a randomized clinical trial for hypofractionated versus normofractionated chemoradiation for glioblastoma

患者报告结局测量和生活质量:一项关于胶质母细胞瘤低分割 versus 常规分割化放疗的随机临床试验

2025-11-010
OAAI
RE-IRRADIATION REGIMENS FOR RECURRENT GLIOMA: SURVIVAL AND TOXICITY

复发性胶质瘤的再照射方案: 生存和毒性

2024-11-110
PRE
Marizomib for patients with newly diagnosed glioblastoma: A randomized phase 3 trial

Marizomib用于新诊断的胶质母细胞瘤患者: 一项随机3期试验

2024-03-192
OAAI
18F-PSMA-11 Versus 68Ga-PSMA-11 Positron Emission Tomography/ Computed Tomography for Staging and Biochemical Recurrence of Prostate Cancer: A Prospective Double-blind Randomised Cross-over Trial

18F-PSMA-11与68Ga-PSMA-11正电子发射断层扫描/计算机断层扫描用于前列腺癌的分期和生化复发: 一项前瞻性双盲随机交叉试验

2022-11-0123
PRE
Trotabresib (CC-90010) in combination with adjuvant temozolomide or concomitant temozolomide plus radiotherapy in patients with newly diagnosed glioblastoma
2022-10-2812
OAAI
Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: a phase III randomized clinical trial

Depatuxizumab mafodotin治疗EGFR扩增的新诊断胶质母细胞瘤: 一项III期随机临床试验

2022-07-1562
OAAI
Efficacy of the eHealth application Oncokompas, facilitating incurably ill cancer patients to self-manage their palliative care needs: A randomized controlled trial
2022-07-0116
OA
Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter

替莫唑胺联合nivolumab或安慰剂用于新诊断的MGMT启动子甲基化的胶质母细胞瘤的放化疗的III期试验

2022-05-02246
OAAI
Non-IDH1-R132H IDH1/2 mutations are associated with increased DNA methylation and improved survival in astrocytomas, compared to IDH1-R132H mutations

与IDH1-R132H突变相比,非R132H位点的IDH1/2突变在星形细胞瘤中表现为DNA甲基化水平升高和生存期延长。

2021-03-1938
OAAI